Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease
Orlikowski D, Pellegrini N, Prigent H, Laforêt P, Carlier R, Carlier P, Eymard B, Lofaso F, Annane D.
Neuromuscul Disord. 2011. 21(7):477-82.
This open-label prospective exploratory study investigated the effect of 12 months of recombinant enzyme replacement therapy in 5 adult patients with severe Pompe disease.
Motor and respiratory function, quantitative muscle testing and spirometry were assessed. Concerning motor function assessed by MFM, 3 patients, wheelchair bound at baseline, improved sitting and proximal motor function and 2 patients improved in their ability to stand and transfer.
Alglucosidase alfa may stabilize or even slightly improve muscle strength and respiratory function among patients with severe Pompe disease.
Keywords: Pompe disease; Alglucosidase alfa; Enzyme replacement therapy; rhGAA
Articles dans les revues scientifiques
Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy
Bonati U, Hafner P, Schädelin S, Schmid M, Naduvilekoot Devasia A, Schroeder J, Zuesli S, Pohlman U, Neuhaus C, Klein A, Sinnreich M, Haas T, Gloor M, Bieri O, Fischmann A, Fischer D. Neuromuscul Disord. 2015. 25(9):679-85. This prospective one year observational...
Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial
Seferian AM, Moraux A, Canal A, Decostre V, Diebate O, Le Moing AG, Gidaro T, Deconinck N, Van Parys F, Vereecke W, Wittevrongel S, Annoussamy M, Mayer M, Maincent K, Cuisset JM, Tiffreau V, Denis S, Jousten V, Quijano-Roy S, Voit T, Hogrel JY, Servais L. PLoS One....
Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial
Seferian AM, Moraux A, Annoussamy M, Canal A, Decostre V, Diebate O, Le Moing AG, Gidaro T, Deconinck N, Van Parys F, Vereecke W, Wittevrongel S, Mayer M, Maincent K, Desguerre I, Thémar-Noël C, Cuisset JM, Tiffreau V, Denis S, Jousten V, Quijano-Roy S, Voit T, Hogrel...
The motor function measure to study limitation of activity in children and adults with Charcot-Marie-Tooth disease
Allard L, Rode G, Jacquin-Courtois S, Pouget MC, Rippert P, Hamroun D, Poirot I, Bérard C, Vuillerot C; le groupe d’étude CMT MFM. Ann Phys Rehabil Med. 2014. 57(9-10):587-99. Study on 233 Charcot-Marie-Tooth disease patients aged 4–86 years aiming at studying the...
Reduced mandibular range of motion in Duchenne Muscular Dystrophy: predictive factors
van Bruggen HW, Van Den Engel-Hoek L, Steenks MH, Bronkhorst EM, Creugers NH, de Groot IJ, Kalaykova SI. J Oral Rehabil. 2015. 42(6):430-8. Objectives were to determine whether the mandibular range of motion in Duchenne Muscular Dystrophy (DMD) is impaired and to...
Is functional dependence of Duchenne muscular dystrophy patients determinant of the quality of life and burden of their caregivers?
Moura MC, Wutzki HC, Voos MC, Resende MB, Reed UC, Hasue RH. Arq Neuropsiquiatr. 2015. 73(1):52-57. This study investigated in Duchenne Muscular Dystrophy possible relationships between functional dependence/QOL of DMD patients and QOL/burden of caregivers.Caregivers...